Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Tharimmune

THAR

THAR Tharimmune NASDAQ
Add to watchlist
--
Market open : Jan 06, 10:52 ET
Summary
Options
Financials
News
Filings
Profile
THAR Chart
See on advanced chart >
All
D
W
M
5m
  • Volume --
  • Turnover --
  • P/E(TTM) --
  • Turnover % --%
  • P/E(Static) --
  • Market Cap --
  • P/B --
  • Shares --
  • 52 Week Range
    --
    --
  • Day Range
    --
    --

About

Tharimmune, Inc. was incorporated on March 28, 2017, as a Delaware corporation. The company is a pre-clinical biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in IMCD for...
  • Highlight
    A biotechnology company developing drug candidates targeting the treatment of ferroptosis
  • Industry
  • Exchange
    NASDAQ
  • Listing Date
    01/12/2022
  • Established Date
    03/28/2017
  • Full-time Employees
    2
  • Address
    1200 Route 22 East Suite 2000 Bridgewater NJ 08807
  • Tel
    1-908-2708260
  • Website
  • Fiscal Year End Date
    12/31
  • Security Type
    Common Stock

Option Block Monitor

You Can Understand Stocks with AI.
Why NVDA surged 16.40%?
Because it
fork
logo
AInvest
Aime Coplilot
Invest Smarter With AI Power.
Open App
All
QUICK
Daily
Weekly
Monthly
Minutes
5 minutes
15 minutes
30 minutes
Ranges
1 Day
1 Week
1 Month
1 Year
YTD